Advertisement
Screener

Axogen, Inc. (AXGN) Investment Income, Nonoperating

3.2 / 5 stars · 63/98 Roast Me

Axogen, Inc. Investment Income, Nonoperating

Axogen, Inc. (AXGN) reported Investment Income, Nonoperating of $28.00 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-10-30.

Discontinued › Income Statement › Other Income

us-gaap:InvestmentIncomeNonoperating · last filed 2020-10-30

  • Axogen, Inc. investment income, nonoperating for the quarter ending 2020-09-30 was $28.00K, a 94.95% decline year-over-year.
  • Axogen, Inc. investment income, nonoperating for the quarter ending 2020-06-30 was $237.00K, a 63.76% decline year-over-year.
  • Axogen, Inc. investment income, nonoperating for the quarter ending 2020-03-31 was $311.00K, a 56.56% decline year-over-year.
  • Axogen, Inc. investment income, nonoperating for the quarter ending 2019-12-31 was $439.00K, a 31.51% decline year-over-year.
  • Axogen, Inc. investment income, nonoperating for fiscal 2019 was $2.36M, a 55.02% increase from fiscal 2018.
  • Axogen, Inc. investment income, nonoperating for fiscal 2018 was $1.52M.
Period endInvestment Income, Nonoperating 3 monthInvestment Income, Nonoperating 3 month as first filedInvestment Income, Nonoperating 6 monthInvestment Income, Nonoperating 6 month as first filedInvestment Income, Nonoperating 9 monthInvestment Income, Nonoperating 9 month as first filedInvestment Income, Nonoperating 12 month
2020-09-30$28.00K
10-Q · filed 2020-10-30
$265.00K
derived: sum of 2 quarters · filed 2020-10-30
$576.00K
10-Q · filed 2020-10-30
$1.01M
derived: sum of 4 quarters · filed 2020-10-30
2020-06-30$237.00K
10-Q · filed 2020-08-07
$548.00K
10-Q · filed 2020-08-07
$987.00K
derived: sum of 3 quarters · filed 2020-08-07
$1.54M
derived: sum of 4 quarters · filed 2020-10-30
2020-03-31$311.00K
10-Q · filed 2020-05-06
$750.00K
derived: sum of 2 quarters · filed 2020-05-06
$1.30M
derived: sum of 3 quarters · filed 2020-10-30
$1.96M
derived: sum of 4 quarters · filed 2020-10-30
2019-12-31$439.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24
$994.00K
derived: sum of 2 quarters · filed 2020-10-30
$1.65M
derived: sum of 3 quarters · filed 2020-10-30
$2.36M
10-K · filed 2020-02-24
2019-09-30$555.00K
10-Q · filed 2020-10-30
$1.21M
derived: sum of 2 quarters · filed 2020-10-30
$1.93M
10-Q · filed 2020-10-30
$2.57M
derived: sum of 4 quarters · filed 2020-10-30
2019-06-30$654.00K
10-Q · filed 2020-08-07
$1.37M
10-Q · filed 2020-08-07
$2.01M
derived: sum of 3 quarters · filed 2020-08-07
$2.74M
derived: sum of 4 quarters · filed 2020-08-07
2019-03-31$716.00K
10-Q · filed 2020-05-06
$1.36M
derived: sum of 2 quarters · filed 2020-05-06
$2.08M
derived: sum of 3 quarters · filed 2020-05-06
$2.24M
derived: sum of 4 quarters · filed 2020-05-06
2018-12-31$641.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24
$1.37M
derived: sum of 2 quarters · filed 2020-02-24
$1.52M
derived: sum of 3 quarters · filed 2020-02-24
$1.52M
10-K · filed 2020-02-24
2018-09-30$727.00K
10-Q · filed 2019-11-06
$727.12K
10-Q · filed 2018-10-29
$883.00K
derived: sum of 2 quarters · filed 2019-11-06
$884.00K
10-Q · filed 2019-11-06
$883.66K
10-Q · filed 2018-10-29
2018-06-30$156.00K
10-Q · filed 2019-08-06
$156.41K
10-Q · filed 2018-08-01
$157.00K
10-Q · filed 2019-08-06
$156.55K
10-Q · filed 2018-08-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
TransMedics Group, Inc. (TMDX)United States$2.911B15.17
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
LivaNova PLC (LIVN)$4.158B24.01
Integer Holdings Corp (ITGR)United States$4.289B25.17
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53